Answers are grounded in this paper and cite their sources.
Tumor lysis syndrome in solid tumors is a rare occurrence, with a poor prognosis. We present the case of a patient of recurrent colon cancer who received chemotherapy with FOLFOX regimen (lencovorin, fluorouracil, and oxaliplatin) with subsequent tumor lysis. We present a recurrent rectal cancer patient suffered from tumor lysis syndrome after salvage FOLFOX regimen. After treat with CVVH with improved conscious status. In this case report, we had review the tumor lysis in solid tumor.
No takes yet. Share an insight, caveat, or question.
Tseng et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: